Market Place
Sourcing Support
Carmell Corporation Appoints New CEO After Russell Microcap Index Addition
29 Jul 2024 //
GLOBENEWSWIRE
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics
12 Sep 2023 //
PR NEWSWIRE
Carmell Announces Completion of Post-Merger Integration with Axolotl Biologix
05 Sep 2023 //
GLOBENEWSWIRE
Carmell Announces Successful Closing of Merger with Axolotl Biologix
09 Aug 2023 //
BUSINESSWIRE
Carmell Therapeutics Announces Merger with Axolotl Biologix
27 Jul 2023 //
BUSINESSWIRE
Carmell Therapeutics plans SPAC deal with Alpha Healthcare, bypassing IPO
05 Jan 2023 //
ENDPTS
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell
04 Jan 2023 //
BUSINESSWIRE
Carmell Gains Alignment with FDA to Evaluate the Use of Its Lead Product
17 Nov 2022 //
BUSINESSWIRE
Carmell Announces Submission of Registration Statement for Public Listing
07 Sep 2022 //
BUSINESSWIRE
Carmell Therapeutics Appoints Sebastian “Sebby” Borriello to CBO
11 May 2022 //
BUSINESSWIRE
Carmell Therapeutics Announces Appointment of Dr. Israel Nur Scientific Advisor
07 Oct 2020 //
BUSINESSWIRE
FDA grants Carmell Therapeutics Expedited Review for CT-101
27 Apr 2020 //
BUSINESSWIRE
FDA grants Carmell Therapeutics Expedited Review for CT-101, Accelerant
27 Apr 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.